Advanced filters
News
In December 2020 AMO- Pharma announced the initiation of the Phase 2/3 clinical trial, REACH-CDM.…
News
These include the first ever national Standards of Care for adults with DMD and the expansion of…
News
This was due to the results from an interim analysis of a clinical trial called SIDEROS, which led…
News
These include the first ever national Standards of Care for adults with DMD and the expansion of…
News
Muscular Dystrophy UK welcomes today’s development. It means adult patients in Scotland will be…
News
We recently posted a blog from Rob Burley, MDUK’s Director for Campaigns, Care and Support, on a…
News
Muscular Dystrophy UK and SMA UK were extremely disappointed to learn earlier this week that,…
News
Recent advances in SMA research have led to the exciting development of genetic therapies, such as…
News
Edasalonexent was a potential treatment for preserving muscle function in patients with Duchenne…
News
Marking Becker awareness week (4 – 10th October), we were joined in our BMD seminar by Professor…